Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-01-16
2007-01-16
Jiang, Shaojia A. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S011400, C514S027000, C514S034000, C514S04400A, C514S171000, C514S251000, C514S283000, C514S449000, C514S559000, C514S681000, C514S682000
Reexamination Certificate
active
10958759
ABSTRACT:
Compositions, methods and the like comprising fucans such as fucoidan to treat surgical adhesions, arthritis, and psoriasis.
REFERENCES:
patent: 5705177 (1998-01-01), Roufa et al.
patent: 6020326 (2000-02-01), Roufa et al.
patent: 6559131 (2003-05-01), Senni et al.
patent: 0 293 826 (1988-12-01), None
patent: 0 645 143 (1995-03-01), None
patent: 0645143 (2000-05-01), None
patent: 2 772 618 (1999-06-01), None
patent: 2772618 (1999-06-01), None
patent: 01-031707 (1989-02-01), None
patent: 64-085905 (1989-03-01), None
patent: 01-313433 (1989-12-01), None
patent: WO 92/19761 (1992-11-01), None
patent: WO 01/82936 (2001-11-01), None
PCT International Search Report, PCT/CA02/01337, Dec. 20, 2002.
Bittuon, Patrick, et al., Low-Molecular-Weight Dextran Derivatives (f-CMDB) Enter The Nucleus And Are Better Cell-Growth Inhibitors Compared With Parent CMDB Polymers, Carbohydrate Research, vol. 322, pp. 247-255 (1999).
Blondin, Catherine, et al., Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) From Brown Seaweed, Molecular Immunology, vol. 31, No. 4, pp. 247-253 (1994).
Brandley, Brian K., et al., Multiple Carbohydrate Receptors on Lymphocytes Revealed by Adhesion to Immobilized Polysaccharides, J. Cell Biology, vol. 105, pp. 991-997 (1987).
Giraux, Jean-Luc, et al., Modulation of Human Endothelial Cell Proliferation and Migration by Fucoidan and Heparin, European J. Cell Biology, vol. 77, pp. 352-359 (1998).
Glabe, Charles G., et al., Reversible Disruption of Cultured Endothelial Monolayers by Sulphated Fucans, J. Cell. Sci., vol. 61, pp. 475-490 (1983).
Itoh, Hiroko, et al., Antitumor Activity and Immunological Properties of Marine Algal Polysaccharides, Especially Fucoidan, Prepared fromSargassum thunbergiiof Phaeophyceae, Anticancer Research, vol. 13, pp. 2045-2052 (1993).
Itoh, Hiroko, et al., Immunological Analysis of Inhibition of Lung Metastases by Fucoidan (GIV-A) Prepared From Brown SeaweedSargassum thunbergii, Anticancer Research, vol. 15, pp. 1937-1948 (1995).
Logearet, Delphine, et al., Fucans, Sulfated Polysaccharides Extracted From Brown Seaweeds, Inhibit Vascular Smooth Muscle Cells Proliferation. I. Comparison With Heparin For Antiproliferative Activity, Binding and Internalization, European J. Cell Biology, vol. 74, pp. 376-384 (1997).
Logearet, Delphine, et al., Fucans, Sulfated Polysaccharides Extracted From Brown Seaweeds, Inhibit Vascular Smooth Muscle Cells Proliferation. II. Degradation and Molecular Weight Effect, European J. of Cell Biology, vol. 74, pp. 385-390 (1997).
Mauray, S., et al., Comparative Ainticoagulant Activity and Influence on Thrombin Generation of Dextran Derivatives and a Fucoidan Fraction, J. Biomater. Sci. polymer. Edn., vol. 9, No. 4, pp. 373-387 (1998).
Nishino, T., et al., Antithrombin Activity of a Fucan Sulfate From The Brown SeaweedEcklonia kurome, Thrombosis Research , vol. 62, pp. 765-773 (1991).
Patankar, Manish S., et al., A revised Structure for Fucoidan May Explain Some of Its Biological Activities, J. Biol. Chem., vol. 268, No. 29, pp. 21770-21776 (1993).
Pereira, Mariana S., et al., Structure and Anticoagulant Activity of Sulfated Fucans, J. Biol. Chem., vol. 274, No. 12, pp. 7656-7667 (1999).
Riou, D., et al., Antitumor and Antiproliferative Effects of a Fucan Extracted FromAscophyllum nodosumAgainst a Non-Small-Cell Bronchopulmonary Carcinoma Line, Anticancer Research, vol. 16, pp. 1213-1218 (1996).
Shibata, Hideyuki, et al., Inhibitory Effect ofCladosiphonFucoidan on the Adhesion ofHelicobacter pylorito Human Gastric Cells, J. Nutr. Sci. Vitaminol., vol. 45, pp. 325-336 (1999).
Soeda, Shinji, et al., Oversulfated Fucoidan Inhibits the Basic Fibroblast Growth Factor-Induced Tube Formation by Human Umbilical Vein Endothelial Cells: its Possible Mechanism of Action, Biochemica et Biophysica Acta, vol. 1497, pp. 124-134 (2000).
Examination Report for New Zealand Application No. 532015, Apr. 29, 2005.
Burt Helen M.
Jackson John K.
Graybeal Jackson Haley LLP
Jiang Shaojia A.
King Joshua
Krishnan Ganapathy
The University of British Columbia
LandOfFree
Pharmaceutical compositions and methods relating to fucans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods relating to fucans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods relating to fucans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3786045